Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Researchers identified new compounds in Platycladi Cacumen and found variations in its flavonoid content, which could aid in its quality control.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Assessing newborn scalp hair can reveal important health information.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Melatonin may help treat PCOS symptoms in rats.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.